456
Registered trials
177
Recruiting
250
Completed trials
203
Sponsors active
69
Research sites
Phase III:
290
Phase II/III:
30
Phase II:
81
Phase I/II:
10
Phase III/IV:
5
Phase IV:
13
Phase I:
12
Phase I (Other):
2
Phase I (FiH):
12
Other:
1
Oversight events in trials active here:
35 serious breaches
170 temporary halts
9 urgent safety measures
11 unexpected events
26 corrective measures
across 73 trials
View oversight register →
Top conditions
Non-small cell lung cancer
18
Amyotrophic lateral sclerosis
8
Ovarian cancer
7
Non-small cell lung cancer metastatic
7
Crohn's disease
6
Idiopathic pulmonary fibrosis
5
Non-small cell lung cancer stage III
5
Fallopian tube cancer
5
Ovarian epithelial cancer
5
Hormone receptor positive HER2 negative breast cancer
4
Hepatocellular carcinoma
4
Non-small cell lung cancer stage II
4
Top sponsors
Merck Sharp & Dohme LLC
57
AbbVie Deutschland GmbH & Co. KG
16
Bristol-Myers Squibb Services Unlimited Company
15
AstraZeneca AB
11
Cancer Trials Ireland
11
University College Dublin
11
Novartis Pharma AG
8
Takeda Development Center Americas Inc.
8
Celgene Corp.
7
Novo Nordisk A/S
7
Regeneron Pharmaceuticals Inc.
7
Boehringer Ingelheim Espana S.A.
6
Cities with most trials
All 20 cities →All trials — page 15
456 totalShowing 337–360 of 456 trials